Prospective multicentre randomized double-blind placebo-controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections

PURPOSE: To evaluate efficacy and safety of vaccination with StroVac compared to placebo in patients with recurrent urinary tract infections (rUTI). MATERIAL AND METHODS: We performed a prospective, double-blinded, placebo-controlled study in patients with uncomplicated rUTI. Patients received three...

Descripción completa

Detalles Bibliográficos
Autores principales: Nestler, S., Peschel, C., Horstmann, A. H., Vahlensieck, W., Fabry, W., Neisius, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Urology - Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870822/
https://www.ncbi.nlm.nih.gov/pubmed/36181584
http://dx.doi.org/10.1007/s11255-022-03379-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870822/
https://www.ncbi.nlm.nih.gov/pubmed/36181584
http://dx.doi.org/10.1007/s11255-022-03379-y

Ejemplares similares